(PATH) Uipath - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 5.459m USD | Total Return: -11.6% in 12m
Avg Turnover: 324M
EPS Trend: 86.0%
Qual. Beats: 1
Rev. Trend: 97.5%
Qual. Beats: 4
Warnings
Altman Z'' -0.46 < 1.0 - financial distress zone
Tailwinds
Confidence
UiPath Inc. (PATH) provides an enterprise-grade automation platform designed to integrate AI agents, robotic process automation (RPA), and API-based workflows. The companys suite includes tools for process orchestration, intelligent document extraction, and centralized governance to coordinate tasks across humans and digital workers. Headquartered in New York, the firm serves global clients in heavily regulated industries such as financial services, healthcare, and manufacturing.
The business operates under a software-as-a-service (SaaS) model, generating revenue primarily through recurring subscriptions for its cloud-based and on-premise automation tools. As a leader in the Systems Software sub-industry, UiPath competes in the rapidly evolving Intelligent Automation market, which shifts traditional RPA toward generative AI-driven agentic workflows. To better understand these competitive dynamics and valuation metrics, consider reviewing the detailed financial breakdowns on ValueRay.
- Transition to agentic AI workflows shifts revenue from legacy RPA to high-margin software
- Subscription ARR growth remains primary metric for valuation and long-term free cash flow
- Competitive pressure from Microsoft Power Automate impacts enterprise pricing and market share expansion
- Global enterprise IT spending cycles dictate pace of large-scale digital transformation contracts
| Net Income: 282.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.41 > 1.0 |
| NWC/Revenue: 83.11% < 20% (prev 107.7%; Δ -24.58% < -1%) |
| CFO/TA 0.12 > 3% & CFO 371.2m > Net Income 282.3m |
| Net Debt (-1.32b) to EBITDA (74.8m): -17.64 < 3 |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (545.3m) vs 12m ago -1.82% < -2% |
| Gross Margin: 83.25% > 18% (prev 0.83%; Δ 8.24k% > 0.5%) |
| Asset Turnover: 53.29% > 50% (prev 49.90%; Δ 3.39% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.42 (Total Current Assets 2.24b - Total Current Liabilities 905.4m) / Total Assets 3.18b |
| B: -0.54 (Retained Earnings -1.71b / Total Assets 3.18b) |
| C: 0.02 (EBIT TTM 57.9m / Avg Total Assets 3.02b) |
| D: -1.52 (Book Value of Equity -1.67b / Total Liabilities 1.10b) |
| Altman-Z'' = -0.46 = B |
| DSRI: 0.95 (Receivables 580.7m/542.3m, Revenue 1.61b/1.43b) |
| GMI: 0.99 (GM 83.25% / 82.69%) |
| AQI: 1.74 (AQ_t 0.26 / AQ_t-1 0.15) |
| SGI: 1.13 (Revenue 1.61b / 1.43b) |
| TATA: -0.03 (NI 282.3m - CFO 371.2m) / TA 3.18b) |
| Beneish M = -2.57 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 10.57 with a total of 37,136,083 shares traded.
Over the past week, the price has changed by +6.43%,
over one month by +8.33%,
over three months by +7.47% and
over the past year by -11.64%.
Uipath has received a consensus analysts rating of 3.17. Therefore, it is recommended to hold PATH.
- StrongBuy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 13.5 | 27.7% |
P/E Forward = 12.9702
P/S = 3.3898
P/B = 2.6914
P/EG = 0.3707
Revenue TTM = 1.61b USD
EBIT TTM = 57.9m USD
EBITDA TTM = 74.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 152.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 81.2m
Net Debt = -1.32b USD (calculated: Debt 152.2m - CCE 1.47b)
Enterprise Value = 4.14b USD (5.46b + Debt 152.2m - CCE 1.47b)
Interest Coverage Ratio = unknown (Ebit TTM 57.9m / Interest Expense TTM 0.0)
EV/FCF = 11.75x (Enterprise Value 4.14b / FCF TTM 352.2m)
FCF Yield = 8.51% (FCF TTM 352.2m / Enterprise Value 4.14b)
FCF Margin = 21.87% (FCF TTM 352.2m / Revenue TTM 1.61b)
Net Margin = 17.53% (Net Income TTM 282.3m / Revenue TTM 1.61b)
Gross Margin = 83.25% ((Revenue TTM 1.61b - Cost of Revenue TTM 269.8m) / Revenue TTM)
Gross Margin QoQ = 84.88% (prev 83.26%)
Tobins Q-Ratio = 1.30 (Enterprise Value 4.14b / Total Assets 3.18b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 152.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = 45.7m (EBIT 57.9m * (1 - 21.00%))
Current Ratio = 2.48 (Total Current Assets 2.24b / Total Current Liabilities 905.4m)
Debt / Equity = 0.07 (Debt 152.2m / totalStockholderEquity, last quarter 2.08b)
Debt / EBITDA = -17.64 (Net Debt -1.32b / EBITDA 74.8m)
Debt / FCF = -3.75 (Net Debt -1.32b / FCF TTM 352.2m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.34% (Net Income 282.3m / Total Assets 3.18b)
RoE = 7.96% (Net Income TTM 282.3m / Total Stockholder Equity 3.55b)
RoCE = 2.54% (EBIT 57.9m / Capital Employed (Total Assets 3.18b - Current Liab 905.4m))
RoIC = 2.41% (NOPAT 45.7m / Invested Capital 1.90b)
WACC = 10.60% (E(5.46b)/V(5.61b) * Re(10.90%) + D(152.2m)/V(5.61b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 10.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -73.33 | Cagr: -1.72%
[DCF] Terminal Value 71.04% ; FCFF base≈333.6m ; Y1≈382.4m ; Y5≈562.7m
[DCF] Fair Price = 16.18 (EV 6.05b - Net Debt -1.32b = Equity 7.37b / Shares 455.8m; r=10.60% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.99 | EPS CAGR: 25.98% | SUE: 1.56 | # QB: 1
Revenue Correlation: 97.52 | Revenue CAGR: 13.52% | SUE: 1.76 | # QB: 4
EPS current Quarter (2026-07-31): EPS=0.15 | Chg30d=+7.20% | Revisions=+33% | Analysts=19
EPS current Year (2027-01-31): EPS=0.80 | Chg30d=+0.40% | Revisions=+20% | GrowthEPS=+11.3% | GrowthRev=+9.1%
EPS next Year (2028-01-31): EPS=0.90 | Chg30d=+0.39% | Revisions=+20% | GrowthEPS=+12.2% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +33%